Skip to main content

Articles

Page 11 of 18

  1. Tuberculosis (TB) has been the most common opportunistic infection and cause of mortality among HIV-infected patients, especially in resource-limited countries. Clinical manifestations of TB vary and depend on...

    Authors: Weerawat Manosuthi, Surasak Wiboonchutikul and Somnuek Sungkanuparph
    Citation: AIDS Research and Therapy 2016 13:22
  2. Despite the combined antiretroviral therapy has improved the length and quality of life of HIV infected patients, the survival of these patients is always decreased compared with the general population. This i...

    Authors: Gabriella d’Ettorre, Giancarlo Ceccarelli, Paolo Pavone, Pietro Vittozzi, Gabriella De Girolamo, Ivan Schietroma, Sara Serafino, Noemi Giustini and Vincenzo Vullo
    Citation: AIDS Research and Therapy 2016 13:21
  3. Cognitive function is reported to improve after the initiation of combination antiretroviral therapy (cART). Data on the evolution of such changes are limited. We assessed the dynamics of changes in cognitive ...

    Authors: Borja Mora-Peris, Elizabeth Stevens, Francesca Ferretti, Jonathan Underwood, Stephen Taylor and Alan Winston
    Citation: AIDS Research and Therapy 2016 13:20
  4. Over the past 10 years, extensive work has been carried out in the field of microbial translocation in HIV infection, ranging from studies on its clinical significance to investigations on its pathogenic featu...

    Authors: Camilla Tincati, Daniel C. Douek and Giulia Marchetti
    Citation: AIDS Research and Therapy 2016 13:19
  5. To describe the development and the psychometric properties of the Istituto Superiore di Sanità-HIV symptoms scale (lSS-HIV symptoms scale).

    Authors: Raffaella Bucciardini, Katherina Pugliese, Daniela Francisci, Andrea Costantini, Elisabetta Schiaroli, Miriam Cognigni, Chiara Tontini, Stefano Lucattini, Luca Fucili, Massimiliano Di Gregorio, Marco Mirra, Vincenzo Fragola, Sara Pompili, Rita Murri and Stefano Vella
    Citation: AIDS Research and Therapy 2016 13:18
  6. In the ANRS EASIER trial where treatment-experienced patients switched from enfuvirtide (ENF) to raltegravir (RAL), a high incidence of transaminase elevation was reported in the RAL arm.

    Authors: Nathalie de Castro, Joséphine Braun, Isabelle Charreau, Alain Lafeuillade, Jean-Paul Viard, Clotilde Allavena, Jean-Pierre Aboulker and Jean-Michel Molina
    Citation: AIDS Research and Therapy 2016 13:17
  7. The uncertain etiology of HIV viral load (VL) blips may lead to increased use of clinical resources. We evaluated the association of self-reported adherence (SRA) and antiretroviral (ART) drug levels on blip o...

    Authors: Aaron Farmer, Xun Wang, Anuradha Ganesan, Robert G. Deiss, Brian K. Agan, Thomas A. O’Bryan, Kevin Akers and Jason F. Okulicz
    Citation: AIDS Research and Therapy 2016 13:16
  8. Women in sub-Saharan Africa continue to be at greater risk for HIV acquisition than men. Concurrency, viz. multiple sexual partnerships that overlap over time, has been studied as a possible risk factor for HI...

    Authors: Zakir Gaffoor, Handan Wand, Renée A. Street, Nathlee Abbai and Gita Ramjee
    Citation: AIDS Research and Therapy 2016 13:14
  9. HIV is usually associated with weight loss. World health Organization (WHO) recommends early antiretroviral (ART) initiation, but data on the progression of body mass index (BMI) in participants initiating ear...

    Authors: Calixte Guehi, Anani Badjé, Delphine Gabillard, Eric Ouattara, Serge Olivier Koulé, Raoul Moh, Didier Ekouevi, Hugues Ahibo, Jean Baptiste N’Takpé, Gérard Kouamé Menan, Nina Deschamps, Jerôme Lecarrou, Serge Eholié, Xavier Anglaret and Christine Danel
    Citation: AIDS Research and Therapy 2016 13:12
  10. Ready-to-use supplementary food (RUSF) is increasingly used as a component of food rations for adults with HIV.

    Authors: Anne G. Beckett, Debbie Humphries, J. Gregory Jerome, Jessica E. Teng, Patrick Ulysse and Louise C. Ivers
    Citation: AIDS Research and Therapy 2016 13:11
  11. Regimen change is a major challenge for the sustainability of human immunodeficiency virus (HIV) treatment program. In a resource limited setting where treatment options are limited, designing strategies to in...

    Authors: Degefaye Zelalem Anlay, Zinahbizu Abay Alemayehu and Berihun Assefa Dachew
    Citation: AIDS Research and Therapy 2016 13:10
  12. Human immunodeficiency virus (HIV) Rapid diagnostic Test (RDT) kits are the preferred assays for HIV testing in many countries. Prevention of Mother-to-Child Transmission, Know Your Status Campaigns, Blood-Saf...

    Authors: Raymond Boadu, George Darko, Priscilla Nortey, Patricia Akweongo and Bismark Sarfo
    Citation: AIDS Research and Therapy 2016 13:9
  13. Long acting antiretroviral drugs represent a promising approach for chronic treatment of HIV infection. Here, we study the efficacy and safety of albuvirtide (ABT), an HIV-1 fusion inhibitor with a half life ...

    Authors: Hongwei Zhang, Ronghua Jin, Cheng Yao, Tong Zhang, Meixia Wang, Wei Xia, Haiyan Peng, Xiaojuan Wang, Rongjian Lu, Changjin Wang, Dong Xie and Hao Wu
    Citation: AIDS Research and Therapy 2016 13:8
  14. Previous studies with BIT225 (N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide) have demonstrated a unique antiviral activity that blocks the release of HIV-1 from monocyte-derived macrophages (MDM). An...

    Authors: Gabriela Khoury, Gary Ewart, Carolyn Luscombe, Michelle Miller and John Wilkinson
    Citation: AIDS Research and Therapy 2016 13:7
  15. Because of the shared mean of transmission, hepatitis B virus (HBV) is one of an important cause of co-morbidity and mortality in peoples living with HIV/AIDS. Hence, the aim of this study was to determine the...

    Authors: Letebrhan Weldemhret, Tsehaye Asmelash, Rashmi Belodu and Dawit Gebreegziabiher
    Citation: AIDS Research and Therapy 2016 13:6
  16. Pre-Exposure Prophylaxis (PrEP) has shown high efficacy in preventing human immunodeficiency virus (HIV) infection among men who have sex with men (MSM) in several large clinical trials, and more recently in “...

    Authors: Hyman M. Scott and Jeffrey D. Klausner
    Citation: AIDS Research and Therapy 2016 13:5
  17. To estimate the adult prevalence of HIV among the adult population in Zambia and determine whether demographic characteristics were associated with being HIV positive.

    Authors: Pascalina Chanda-Kapata, Nathan Kapata, Eveline Klinkenberg, Ngosa William, Liwewe Mazyanga, Katoba Musukwa, Elizabeth Chizema Kawesha, Felix Masiye and Peter Mwaba
    Citation: AIDS Research and Therapy 2016 13:4
  18. Since the first HIV-1 case in 1989, Hebei province has presented a clearly rising trend of HIV-1 prevalence, and HIV-1 genetic diversity has become the vital barrier to HIV prevention and control in this area....

    Authors: Xinli Lu, Cuiying Zhao, Wei Wang, Chenxi Nie, Yuqi Zhang, Hongru Zhao, Suliang Chen and Ze Cui
    Citation: AIDS Research and Therapy 2016 13:3
  19. Rates of first antiretroviral therapy (cART) modifications are high in most observational studies. The age-related differences in treatment duration and characteristics of first cART modifications remain under...

    Authors: Justyna D. Kowalska, Joanna Kubicka, Ewa Siwak, Piotr Pulik, Ewa Firląg-Burkacka and Andrzej Horban
    Citation: AIDS Research and Therapy 2016 13:2
  20. Novel fourth generation screening and confirmatory human immunodeficiency virus (HIV) assays are now commercially available and incorporated into new diagnostic algorithms. We report two cases involving a tota...

    Authors: Peter Liu, Patrick Jackson, Nathan Shaw and Scott Heysell
    Citation: AIDS Research and Therapy 2016 13:1
  21. This short report arose from a follow-up study of children previously diagnosed with human immunodeficiency virus (HIV) encephalopathy and spastic diplegia and is among the first to describe that increased low...

    Authors: Theresa N. Mann, Kirsten A. Donald, Kathleen G. Walker and Nelleke G. Langerak
    Citation: AIDS Research and Therapy 2015 12:43
  22. The risk of cardiovascular diseases (CVD) in human immunodeficiency virus (HIV) infected people on antiretroviral therapy (ART) from some rural parts of Africa is not well known. We assessed CVD risk factors, ...

    Authors: Felistas Mashinya, Marianne Alberts, Jean-Pierre Van geertruyden and Robert Colebunders
    Citation: AIDS Research and Therapy 2015 12:42
  23. Late diagnosis and presentation to human immune deficiency virus (HIV)/acquired immune deficiency syndrome care reduce the benefits of antiretroviral therapy and increase the risk of HIV transmission.

    Authors: Yalemzewod Assefa Gelaw, Goitom Halefom Senbete, Akelew Awoke Adane and Kefyalew Addis Alene
    Citation: AIDS Research and Therapy 2015 12:40
  24. An increasing number of patients in Africa are experiencing virologic failure on second-line antiretroviral therapy (ART) and those who develop resistance to protease inhibitors (PI) will require third-line A...

    Authors: Graeme Meintjes, Liezl Dunn, Marla Coetsee, Michael Hislop, Rory Leisegang, Leon Regensberg and Gary Maartens
    Citation: AIDS Research and Therapy 2015 12:39
  25. Access to antiretroviral treatment (ART) in resource-limited countries has increased significantly but scaling-up ART into semi-rural and rural areas is more recent. Information on treatment outcome in such ar...

    Authors: Abla A. Konou, Mounerou Salou, Nicole Vidal, Pascal Kodah, Damobé Kombate, Pyabalo Kpanla, Tchabia Nabroulaba, Djifa Nyametso, Assétina Singo-Tokofaï, Palokinam Pitche, Eric Delaporte, Mireille Prince-David, Martine Peeters and Anoumou Y. Dagnra
    Citation: AIDS Research and Therapy 2015 12:38
  26. Community-drug distribution point is a care model for stable patients in the community designed to make ART delivery more efficient for the health system and provide appropriate support to encourage long-term ...

    Authors: Stephen Okoboi, Erin Ding, Steven Persuad, Jonathan Wangisi, Josephine Birungi, Susan Shurgold, Darius Kato, Maureen Nyonyintono, Aggrey Egessa, Celestin Bakanda, Paula Munderi, Pontiano Kaleebu and David M. Moore
    Citation: AIDS Research and Therapy 2015 12:37
  27. The development of HIV related pulmonary arterial hypertension (PAH) reduces the probability of survival by half as compared with HIV-infected individuals without HIV related PAH. HIV infected patients have a ...

    Authors: Jean Joel R. Bigna, Paule Sandra D. Sime and Sinata Koulla-Shiro
    Citation: AIDS Research and Therapy 2015 12:36
  28. Identifying those at increased risk of death during TB treatment is a priority in resource-constrained settings. We performed this study to determine predictors of mortality during TB treatment.

    Authors: Dominique J. Pepper, Michael Schomaker, Robert J. Wilkinson, Virginia de Azevedo and Gary Maartens
    Citation: AIDS Research and Therapy 2015 12:35
  29. CCR5-using (r5) HIV-1 predominates during asymptomatic disease followed by occasional emergence of CXCR4-using (x4) or dual tropic (r5x4) virus. We examined the contribution of the x4 and r5 components to repl...

    Authors: Immaculate L Nankya, Denis M Tebit, Awet Abraha, Fred Kyeyune, Richard Gibson, Oyebisi Jegede, Gabrielle Nickel and Eric J Arts
    Citation: AIDS Research and Therapy 2015 12:34
  30. Cryptococcal meningitis is one of the most lethal fungal infections in patients with acquired immune deficiency syndrome (AIDS). The incidence of and mortality from cryptococcal meningitis have markedly decrea...

    Authors: Hideki Hashimoto, Shuji Hatakeyama and Hiroshi Yotsuyanagi
    Citation: AIDS Research and Therapy 2015 12:33
  31. The objective of this study was to determine the rate of acquired immune deficiency syndrome (AIDS) in Zhejiang province and to identify specific factors associated with progression of this disease.

    Authors: Lin Chen, Jiezhe Yang, Renjie Zhang, Yun Xu, Jinlei Zheng, Jianmin Jiang, Jun Jiang, Lin He, Ning Wang, Philip Chun Yeung and Xiaohong Pan
    Citation: AIDS Research and Therapy 2015 12:32
  32. We evaluated the effectiveness of darunavir (DRV) treatment plus an optimized background regimen in 120 HIV-1 treatment-experienced patients.

    Authors: José Antonio Mata-Marín, Gloria Huerta-García, Juan Carlos Domínguez-Hermosillo, Marcelino Chavez-García, Marco Isaac Banda-Lara, Nohemí Nuñez-Rodríguez, Javier Enrique Cruz-Herrera, Jorge Luis Sandoval-Ramírez, Ivan Martínez-Abarca, Alfredo Francisco Villagómez-Ruíz, Bulmaro Manjarrez-Tellez and Jesús Gaytán-Martínez
    Citation: AIDS Research and Therapy 2015 12:31
  33. Protease inhibitors (PI)s have been associated with distal sensory polyneuropathy (DSP) and metabolic complications in high-income countries. No data exist in Africans where second-line antiretroviral therapy ...

    Authors: John-Randel Vermaak, Joel A. Dave, Naomi Levitt and Jeannine M. Heckmann
    Citation: AIDS Research and Therapy 2015 12:30
  34. Alcohol consumption is prevalent amongst HIV positive population. Importantly, chronic alcohol use is reported to exacerbate HIV pathogenesis. Although alcohol is known to increase oxidative stress, especially...

    Authors: Anusha Ande, Namita Sinha, P. S. S. Rao, Carole P. McArthur, Leo Ayuk, Paul N. Achu, Annette Njinda, Anil Kumar and Santosh Kumar
    Citation: AIDS Research and Therapy 2015 12:29
  35. Human leukocyte antigen (HLA)-B*5701 is strongly associated with developing a hypersensitivity reaction to abacavir (ABC). Limited data exist on HLA-B*5701 prevalence in HIV-1-infected subjects in China. We in...

    Authors: Hongwei Zhang, Tong Zhang, Hongxin Zhao, Ning Han, Haiwei Zhou, Yun He, Qingxia Zhao, Hong Li, Huiqin Li, Mi Zhang, Jianjian Li, Yongtao Sun, Ke Zhao, Qing Liu, Zhiying Liu, Zhen Li…
    Citation: AIDS Research and Therapy 2015 12:28
  36. Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations a...

    Authors: Valentine Budambula, Francis O. Musumba, Mark K. Webale, Titus M. Kahiga, Francisca Ongecha-Owuor, James N. Kiarie, George A. Sowayi, Aabid A. Ahmed, Collins Ouma and Tom Were
    Citation: AIDS Research and Therapy 2015 12:27
  37. HIV infected children experience a range of hematological complications which show marked improvement within 6 months of initiating anti-retroviral therapy. The Objectives of the study was to describe the chan...

    Authors: Elizabeth Gathoni Kibaru, Ruth Nduati, Dalton Wamalwa and Nyambura Kariuki
    Citation: AIDS Research and Therapy 2015 12:26
  38. India has a large number of HIV infected patients being followed up at anti-retroviral therapy (ART) centers. The patients are regularly offered CD4 count estimation for deciding their eligibility for ART init...

    Authors: Ashwini Shete, Dharmesh P Singh, Bharati Mahajan, Amol Kokare, Ramesh Paranjape and Madhuri Thakar
    Citation: AIDS Research and Therapy 2015 12:25
  39. A number of metabolic abnormalities, such as dysglycaemia, insulin resistance, lipodystrophy and dyslipidaemia, are associated with the use of antiretroviral drugs. We aimed to assess the effects of long-term ...

    Authors: Zulfa Abrahams, Joel A Dave, Gary Maartens and Naomi S Levitt
    Citation: AIDS Research and Therapy 2015 12:24
  40. It is a challenge to differentiate between HIV-associated neurocognitive disorders (HAND) and other types of neurocognitive disease in the ageing HIV-infected population. Here we describe a 63 year old HIV-inf...

    Authors: Signar Mäkitalo, Åsa Mellgren, Ellen Borgh, Lena Kilander, Tobias Skillbäck, Henrik Zetterberg and Magnus Gisslén
    Citation: AIDS Research and Therapy 2015 12:23
  41. In Henan, China, first-line antiretroviral treatment (ART) was implemented early in a large number of treatment-experienced patients who were more likely to have a drug resistance. Therefore, we investigated t...

    Authors: Jia Liu, Yasong Wu, Wenjie Yang, Xiujuan Xue, Guoqing Sun, Chunhua Liu, Suian Tian, Dingyong Sun, Qian Zhu and Zhe Wang
    Citation: AIDS Research and Therapy 2015 12:22
  42. Lipodystrophy (LD) is a frequent adverse event of combination antiretroviral therapy (ART) and occurs mainly in patients exposed to first-generation antiretroviral drugs. The aim of this study was to explore a...

    Authors: Charlotte M Verolet, Cécile Delhumeau-Cartier, Marlène Sartori, Simona Toma, Sophie Zawadynski, Minerva Becker, Enos Bernasconi, Laurence Toutous Trellu and Alexandra Calmy
    Citation: AIDS Research and Therapy 2015 12:21
  43. Trends in prevalence of opportunistic infections (OIs) associated with the human immunodeficiency virus (HIV) in resource poor settings have previously not been well documented. The objective of this study was...

    Authors: John Rubaihayo, Nazarius M Tumwesigye and Joseph Konde-Lule
    Citation: AIDS Research and Therapy 2015 12:20
  44. Estimates of the interval from HIV-1 infection to disease progression may be affected by selection bias, and data concerning asymptomatic early seroconverters are limited. We examined the interval until diseas...

    Authors: Dai Watanabe, Sachiko Suzuki, Misa Ashida, Yuka Shimoji, Kazuyuki Hirota, Yoshihiko Ogawa, Keishiro Yajima, Daisuke Kasai, Yasuharu Nishida, Tomoko Uehira and Takuma Shirasaka
    Citation: AIDS Research and Therapy 2015 12:19
  45. A 21 year old MSM patient with newly diagnosed HIV infection was hospitalized in our department after ingestion of an overdose of his antiretroviral therapy (ART) comprising dolutegravir (DTG - Tivicay®) and t...

    Authors: Marcel Lee, Florian Eyer, Norbert Felgenhauer, Hartwig HF Klinker and Christoph D Spinner
    Citation: AIDS Research and Therapy 2015 12:18
  46. To determine the levels of NT-pro BNP in HIV patients over 40 years who are receiving highly active antiretroviral therapy (HAART) and investigating potential independent clinical or laboratory factors.

    Authors: Julián Olalla, Elena Crespo, Javier De la Torre, Marco Sempere, Alfonso Del Arco, José Luis Prada, Rocío Malvarez, Javier Pérez and Javier García-Alegría
    Citation: AIDS Research and Therapy 2015 12:17
  47. Sporotrichosis is an infection caused by a dimorphic fungus of the Sporothrix schenckii complex. Host immunity is an important factor in the clinical manifestations of the disease. Deeply immunocompromised indivi...

    Authors: Ariane Gomes Paixão, Maria Clara Gutierrez Galhardo, Rodrigo Almeida-Paes, Estevão Portela Nunes, Marcelo Luiz Carvalho Gonçalves, Gisele Larias Chequer and Cristiane da Cruz Lamas
    Citation: AIDS Research and Therapy 2015 12:16